Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 21, 2023

SELL
$2.2 - $4.2 $82,500 - $157,500
-37,500 Reduced 25.0%
112,500 $267,000
Q2 2022

Aug 15, 2022

SELL
$2.2 - $4.2 $82,500 - $157,500
-37,500 Reduced 25.0%
112,500 $268,000
Q1 2022

Sep 21, 2023

BUY
$2.83 - $8.69 $424,500 - $1.3 Million
150,000 New
150,000 $604,000
Q1 2022

May 16, 2022

BUY
$2.83 - $8.69 $424,500 - $1.3 Million
150,000 New
150,000 $605,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.